Cargando…
USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer
Gastric cancer (GC) ranks the third leading cause of global cancer mortality. Despite recent progress in surgery combined with chemotherapy, the outcomes of GC patients have barely improved. Therefore, better understanding of the molecular mechanisms involved in chemoresistance of GC may help develo...
Autores principales: | Fu, Ying, Ma, Gang, Liu, Guolong, Li, Bin, Li, Hui, Hao, Xishan, Liu, Liren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246950/ https://www.ncbi.nlm.nih.gov/pubmed/30296012 http://dx.doi.org/10.1002/cam4.1770 |
Ejemplares similares
-
Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway
por: Zhou, Danyang, et al.
Publicado: (2018) -
The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
por: Tian, Xin‐Yuan, et al.
Publicado: (2020) -
Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer
por: Li, Xiang, et al.
Publicado: (2019) -
Alendronate‐anchored PEGylation of ceria nanoparticles promotes human hepatoma cell proliferation via AKT/ERK signaling pathways
por: Cheng, Heng, et al.
Publicado: (2017) -
Identification of a 6‐lncRNA prognostic signature based on microarray re‐annotation in gastric cancer
por: Ma, Bin, et al.
Publicado: (2019)